Trade INKT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
MiNK Therapeutics, Inc. (INKT) is trading at US$11.45, down 1.63% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$62.26M. Over the past 52 weeks, INKT has traded between US$8.48 and US$16.98. On Syfe you can trade INKT with $0 commission and add it to your watchlist.
| Previous close | US$11.64 |
|---|---|
| Market cap | US$62.26M |
| 52-week range | US$8.48 – US$16.98 |
| Volume | 10.76K |
| Exchange | US |
Add to Watchlist
Set Price Alert
MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.
Year: 2021
MiNK Therapeutics, Inc. (INKT) stock is trading at US$11.45, -1.63% from the previous close of US$11.64.
The market cap for MiNK Therapeutics, Inc. (INKT) stock is approximately US$62.26M.
The 52-week high for MiNK Therapeutics, Inc. (INKT) stock is US$16.98.
The 52-week low for MiNK Therapeutics, Inc. (INKT) stock is US$8.48.
MiNK Therapeutics, Inc. (INKT) does not currently pay a dividend.
Stay on top of INKT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
